Brief: Shanghai Heartcare Medical Technology's Registration Application Accepted For Intracranial Drug-Eluting Stent
20/01/2026 15:07
Jan 20 (Reuters) - Shanghai HeartCare Medical Technology Corp Ltd 6609.HK: REGISTRATION APPLICATION OF SELF-EXPANDING INTRACRANIAL DRUG-ELUTING STENT ACCEPTED BY NMPA CHINA Further company coverage: 6609.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai HeartCare Medical Technology
See all newsBrief: Shanghai Heartcare Medical Technology Says Board Did Not Declare Payment Of An Interim Dividend
China's HeartCare Medical H1 revenue surges on stroke segment growth
Brief: Shanghai Heartcare Medical Technology Expects HY Revenue Of No Less Than Rmb280 Million
Brief: Shanghai Heartcare Medical Technology Approves H Share Repurchase Plan Up To HKD100 Million For Up To 1 Million H Shares
Brief: Shanghai HeartCare Medical Technology Sees FY PBT RMB80 Million